Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
Lin Li(Virginia Commonwealth University), Shirong Cai
Cited by 19
Related Papers
Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers
|Frontiers in Oncology|2023|110
Cross-talk between the H3K36me3 and H4K16ac histone epigenetic marks in DNA double-strand break repair
|Journal of Biological Chemistry|2017|86
Lysine acetyltransferase 8 is involved in cerebral development and syndromic intellectual disability
|Journal of Clinical Investigation|2019|69
Protective effects of physiological testosterone on advanced glycation end product-induced injury in human endothelial cells
|Molecular Medicine Reports|2017|10
YY1 is involved in homologous recombination inhibition at guanine quadruplex sites in human cells
|Nucleic Acids Research|2024|6